Omics from Research to Clinic: Unraveling the Underlying Biology of Alzheimer's Disease - Yuetiva Robles (Deming), PhD

Yuetiva Robles (Deming), PhD, is a postdoctoral fellow in the Division of Geriatrics and Gerontology investigating genetic associations with quantitative traits to help further understanding of Alzheimer’s disease. She earned her PhD in Neuroscience from Washington University in St Louis School of Medicine. Her research focuses on disease biomarkers and endophenotypes, integrating genomics, proteomics, metabolomics, biostatistics, and bioinformatics methods to help uncover biological pathways associated with AD pathology. Dr. Robles is working toward developing methods for early detection of AD and identifying therapeutic targets to help slow or prevent the progression of disease.

Learning Objectives

Upon completion of this educational activity, participants will be able to:

  1. Name the omics of the extended Central Dogma of Molecular Biology.
  2. Describe key neuropathological hallmarks of Alzheimer’s disease.
  3. Identify the ATN biomarker profiles for the research definition of Alzheimer’s disease.
Course summary
Available credit: 
  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
Registration opens: 
01/09/2020
Course expires: 
01/08/2021
Cost:
$0.00
Rating: 
0

Yuetiva Robles, PhD
Presenter

Steven R. Barczi, MD
RSS Chair

Robert M. Breslow, RPh
Planning Committee
Erin Chin, BS
Planning Committee
Elizabeth N. Chapman, MD
Planning Committee
Rebecca Wasieleski, BA
Planning Committee
Stephanie Savoie, MSN, RN
Planning Committee
Sheryl Spensley, BS
Planning Committee
Toni Hofhine, BS
Planning Committee
Amanda Salm, BS
RSS Coordinator
Jessica Carlucci-Jenkins
ICEP Staff
Kim Sprecker
ICEP Staff

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison ICEP that the faculty, authors, planners, and other persons who may influence content of this CE activity disclose all relevant financial relationships with commercial interests* in order to allow CE staff to identify and resolve any potential conflicts of interest. Faculty must also disclose any planned discussions of unlabeled/unapproved uses of drugs or devices during the educational activity. For this educational activity all conflicts of interests have been resolved and detailed disclosures are listed below:

Yuetiva Robles, PhD: Amgen: Member of Neuroscience Scientific Advisory Board.
Steven R. Barczi, MD: No relevant relationships to disclose in regard to this activity.
Robert M. Breslow, RPh: No relevant relationships to disclose in regard to this activity.
Elizabeth N. Chapman, MD: No relevant relationships to disclose in regard to this activity.
Laury Jensen, RN: No relevant relationships to disclose in regard to this activity.
Stephanie Savoie, MSN, RN: No relevant relationships to disclose in regard to this activity.
Amanda Salm, BS: No relevant relationships to disclose in regard to this activity.
Jessica Carlucci-Jenkins, BA: No relevant relationships to disclose in regard to this activity.
Kim Sprecker: No relevant relationships to disclose in regard to this activity.

* The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME does not consider providers of clinical service directly to patients to be commercial interests.

Disclosure of Unlabeled Use: The University of Wisconsin–Madison ICEP advises the participant that this continuing medical education activity does NOT contain reference(s) to unlabeled or unapproved uses of drugs or devices

Discloser List CME Internal Report

Accreditation Statement

In support of improving patient care, the University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Credit Designation Statements

Accreditation Council for Pharmacy Education (ACPE)

A maximum of 1 hour of knowledge-based CE credit can be earned by successfully completing this live activity. Pharmacists should claim only the credit commensurate with the extent of their participation in the activity. CE credit information, based on verification of live attendance, will be provided to NABP within 60 days after the activity completion. 2020 Universal Activity Number (UAN): JA0000358-0000-20-044-H04-P

American Medical Association

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

American Nurses Credentialing Center (ANCC)

The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 1 ANCC contact hour.  

The University of Wisconsin–Madison School of Nursing is Iowa Board of Nursing provider 350. 

Continuing Education Units

The University of Wisconsin–Madison, as a member of the University Continuing Education Association (UCEA), authorizes this program for .01 continuing education units (CEUs) or 1 hour.

Available Credit

  • 1.00 ACPE Contact Hours - Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC Contact Hours
  • 1.00 University of Wisconsin–Madison Continuing Education Hours

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Free, current version of Internet Explorer, Firefox, Safari, or Chrome with audio. Some older browsers and Microsoft Edge could produce error messages or not display the content correctly.